Therefore, we hypothesized that the reduction of prolactin by improving insulin sensitivity have favored the increase of IGF-1 in patients with overweight and obesity. However the IGF-1 increase was within normal range with the exception of two cases in whom acromegaly was ruled out. Here, IGF1 is linked to obesity disorder.